WuXi Biologics reached its first GMP batch release 15 months after purchasing the SA25 Aseptic Filling Workcell.

WuXi Biologics

CDMO WuXi Biologics installed the Vanrx SA25 Aseptic Filling Workcell at its DP4 drug product operations, reaching its first GMP batch release 15 months after purchasing the machine in 2018. As of April 2020, WuXi Biologics is filling vials, syringes and cartridges for clients at clinical and commercial levels with a quality acceptance rate of up to 99.5% of units produced.

“Featuring modularization, robotic automation and a closed system, this state-of-the-art line reflects our leadership in biologics manufacturing innovation. DP4 has demonstrated our diverse aseptic filling capabilities, maintaining high product quality and extensive flexibility to serve the complex biologics filling needs of our clients.”

Dr. Chris Chen
CEO, WuXi Biologics

DP4 has successfully completed 13 batches of drug product filling and passed six audits with no critical findings. Inspectors included former U.S. FDA officers and EU Qualified Persons. The company has booked 50 future filling projects on the SA25 at DP4.

Matching technology with customer needs

WuXi Biologics chose Vanrx’s SA25 Aseptic Filling Workcell to act as a flexible filler for clinical and small-volume commercial drug products being filled into vials, syringes and cartridges. The selection team’s goals were flexibility, quality assurance and technology transfer:

  • Fill vials, syringes and cartridges with short decontamination cycles.
  • Designed for maximizing yields and reducing rejection rates.
  • Accelerated technology transfer with a standard machine, where new products / recipes can be added quickly.
Robotic handling of nested vials in the SA25 Aseptic Filling Workcell at WuXi Biologics.

What did the project team achieve?

AreaAchievement
FlexibilityBy the time of GMP release, the SA25 was validated for 1 mL long syringes, 1-3 mL syringes, 5 mL syringes, 10 mL syringes and 2R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R and 50R vials. Typical decontamination times range from 25-40 minutes, including aeration.
Quality assuranceUp to 99.5% acceptance rate of units produced.

Technology transfer
50 filling projects booked on the machine as of April 2020. Additional SA25 units planned for scale out expansion.

WuXi Biologics’ success with their first SA25 Aseptic Filling Workcell will be expanded with their recent purchase of several more machines. As standard systems, these additional Workcells can be built and validated quickly. Once ready, recipes from one machine can be transferred to the others to scale out production.

Vanrx SA25 Aseptic Filling Workcell installed in WuXi Biologics' DP4 facility.

“WuXi Biologics will continue to invest in cutting-edge technologies to fulfill our mission, enabling global partners to advance product approvals for the benefits of patients worldwide.”

Dr. Chris Chen
CEO, WuXi Biologics

Find out more about aseptic filling with WuXi Biologics at wuxibiologics.com.